Mayim Bialik's Breakdown50 Million in Funding, 10,000 New Clinics, and the Mistake That Could Kill the Psychedelic Revolution | Dr. Rick DoblinCapitalism vs Altruism in Pharma
44:27–45:27 · 60s
Doblin contrasts shareholder-driven drug companies with MAPS’s public-benefit model, calling profit-first medicine a cancerous growth.